Bellevue Life Sciences Acquisition Corp. (BLACU) NASDAQ
$11.29 - (-)
Market Cap: $60.17M
As of 02/16/24 12:00 AM EST. Market closed.
Bellevue Life Sciences Acquisition Corp. (BLACU)
NASDAQ
$11.29
- (-)
Market Cap: $60.17M
As of 02/16/24 12:00 AM EST. Market closed.
Add to Portfolio
... read more
COMPANY PROFILE
Sector
Industry
URL
Address
.
Sector
Industry
URL
Address
.
PRICE CHART FOR BELLEVUE LIFE SCIENCES ACQUISITION CORP
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
$11.29
Days Range
$11.29 - $11.29
52 week range
$10.09 - $11.29
Volume
40
Avg. Volume (30 days)
0
Market Cap
$60.17M
Dividend Yield
-
P/E
-
Shares Outstanding
6,430,000
Open
-
Previous Close
$11.29
Days Range
$11.29 - $11.29
52 week range
$10.09 - $11.29
Volume
40
Avg. Volume (30 days)
0
Market Cap
$60.17M
Dividend Yield
-
P/E
-
Shares Outstanding
6,430,000
FINANCIAL STATEMENTS FOR BELLEVUE LIFE SCIENCES ACQUISITION CORP
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR BELLEVUE LIFE SCIENCES ACQUISITION CORP
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Bellevue Global Life Science Investors LLC | 10% Owner | Feb 14, 2023 | Option Exercise | $10.00 | 430,000 | 4,300,000 | 1,800,000 | Feb 16, 2023, 07:52 PM |
| Hwang Kuk Hyoun | Chief Executive Officer | Feb 14, 2023 | Option Exercise | $10.00 | 430,000 | 4,300,000 | 1,800,000 | Feb 16, 2023, 07:51 PM |
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Bellevue Global Life Science Investors LLC | 10% Owner | 02/14/2023 | 4,300,000 |
| Hwang Kuk Hyoun | Chief Executive Officer | 02/14/2023 | 4,300,000 |
CHANGE IN SHARES OUTSTANDING FOR BELLEVUE LIFE SCIENCES ACQUISITION CORP
STOCK BUYBACKS FOR BELLEVUE LIFE SCIENCES ACQUISITION CORP
Period of Report: 12/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2023
-18.16%
1Q
06/30/2023
-18.16%
2Q
BUYBACK ANNOUNCEMENT(S) FOR BELLEVUE LIFE SCIENCES ACQUISITION CORP
LOADING...